SBC Medical profit margin SBC
Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.
- Net margin, 12 months
- 28.0%
- Operating margin, 12 months
- 37.3%
- Net margin on a year earlier
- +10.3 pts
- Peer median
- 4.4%
Over the twelve months to Jun 30, 2026, SBC Medical kept 28.0% of its revenue as net profit, with an operating margin of 37.3% and a gross margin of 71.9%.
The median for 10 hospital and care facility stocks of a similar size is 4.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 29.4% | 38.9% | 73.3% |
| FY2024 | 22.7% | 34.2% | 76.0% |
| FY2023 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 28.0% | +10.3 pts | 37.3% | |
| Q1 FY26 | 24.1% | −0.8 pts | 36.0% | |
| Q4 FY25 | 29.4% | +6.7 pts | 38.9% | |
| Q3 FY25 | 24.3% | +6.5 pts | 33.3% | |
| Q2 FY25 | 17.7% | −3.1 pts | 30.5% | |
| Q1 FY25 | 24.9% | n/a | 35.4% | |
| Q4 FY24 | 22.7% | n/a | 34.2% | |
| Q3 FY24 | 17.8% | n/a | 29.1% | |
| Q2 FY24 | 20.8% | n/a | 32.7% | |
| Q1 FY24 | n/a | n/a | n/a | |
| Q4 FY23 | n/a | n/a | n/a | |
| Q3 FY23 | n/a | n/a | n/a |
Against its peers
Companies in Medical - Care Facilities nearest SBC Medical's size, closest first, today.
| Company | Profit margin |
|---|---|
| SBCSBC Medical | 28.0% |
| VMDViemed Healthcare | 4.8% |
| OMDAOmada Health | 1.4% |
| USPHU S Physical Therapy | 4.0% |
| PNTGPennant | 2.9% |
| ARDTArdent Health | 1.2% |
| HCSGHealthcare Services | 6.6% |
| PGNYProgyny | 6.0% |
| ADUSAddus HomeCare | 7.1% |
| MDPediatrix Medical | 9.0% |
| PRVAPrivia Health | 1.2% |
| Peer median | 4.4% |
Where SBC Medical ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on SBC Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.